IP Library Granted Patent US 6,881,589
Granted Patent B1
US 6,881,589 · App. 08/465,443 · Granted Apr 19, 2005

Electrochemiluminescent localizable complexes for assay compositions

Assignee: BioVeris Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,881,589
App. No.
08/465,443
Granted
Apr 19, 2005
Kind
B1
Abstract

The invention provides compositions and kits for performing a binding assay for an analyte of interest present in a sample based upon electrochemiluminescence. The compositions and kits comprise an electrochemiluminescent label, collectable particles, binding reagents, and an electrolyte.

Claims (122)

1. An electrochemiluminescent composition suitable for use in an electrochemiluminescent assay for an analyte of interest, comprising:

(a) an electrochemiluminescent label;

(b) a first binding reagent comprising a binding partner of (i) said analyte of interest, (ii) an analog of said analyte of interest, (iii) a binding partner of said analyte of interest, or (iv) a binding partner of said analog of said analyte of interest, wherein said first binding reagent is also a binding partner of or linked to said label;

(c) collectable magnetic particles;

(d) a second binding reagent comprising a binding partner of (i) said analyte of interest, (ii) an analog of said analyte of interest, (iii) a binding partner of said analyte of interest, or (iv) a binding partner of said analog of said analyte of interest wherein said second binding reagent is also a binding partner of or linked to said particles; and

(e) an electrolyte

wherein said composition is suitable for use in said assay for said analyte of interest.

2. The composition of claim 1 , wherein the electrolyte functions as a pH buffer for the composition.

3. The composition of claim 1 , wherein the electrolyte comprises a mixture of KH 2 PO 4 and K 2 HPO 4 .

4. The composition of claim 3 , wherein the electrolyte is in an aqueous solution.

5. The composition of claim 1 , wherein the first binding reagent is chemically distinct from the second binding reagent.

6. The composition of claim 1 , wherein the first binding reagent and second binding reagent are each comprised of the same substance.

7. The composition of claim 1 , wherein said composition is suitable for use in a noncompetitive assay and forms complexes in the presence of said analyte of interest and the complexes contain the analyte and components (a), (b), (c) and (d).

8. The composition of claim 7 , wherein said electrochemiluminescent label comprises a Ru-containing or Os-containing organometallic compound.

9. The composition of claim 1 , wherein said composition is suitable for use in a competitive assay, wherein in the absence of analyte said composition forms complexes comprising components (a), (b), (c), and (d) and, wherein the presence of said analyte inhibits the formation of said complexes.

10. The composition of claim 1 , wherein said analyte of interest is selected from the group consisting of a whole cell or surface antigen, subcellular particle, virus, prion, viroid, antibody, antigen, hapten, fatty acid, nucleic acid, protein, lipoprotein, polysaccharide, lipopolysaccharide, glycoprotein, peptide, polypeptide, cellular metabolite, hormone, pharmacological agent, synthetic organic molecule, organometallic molecule, tranquilizer, barbiturate, alkaloid, steroid, vitamin, amino acid, sugar, lectin, recombinant or derived protein, biotin, avidin, streptavidin and inorganic molecule.

11. The composition of claim 1 , wherein said electrochemiluminescent label comprises an organometallic compound.

12. The composition of claim 1 , wherein said electrochemiluminescent label comprises a Ru-containing or Os-containing organometallic compound.

13. The composition of claim 1 , wherein the size of said particles, measured as the mean diameter, is from 0.05 to 10 μm.

14. The composition of claim 1 , wherein the label comprises a derivative of ruthenium(II) tris-(2,2′-bipyridine).

15. The composition of claim 1 , wherein the particles respond to gravity.

16. The composition of claim 1 , wherein the particles respond to centrifugation.

17. The composition of claim 1 , wherein the particles respond to filtration.

18. An electrochemiluminescent composition suitable for use in an electrochemiluminescent assay for an analyte of interest comprising:

(a) an electrochemiluminescent label;

(b) a first reagent comprising (i) a first binding partner of said analyte of interest or (ii) a first binding competitor of said analyte of interest, wherein said first reagent is linked to or is a binding partner of said label;

(c) collectable magnetic particles;

(d) a second reagent comprising (i) a second binding partner of said analyte of interest or (ii) a second binding competitor of said analyte of interest, wherein said second reagent is linked to or is a binding partner of said particles; and

(e) an electrolyte.

19. The composition of claim 18 , wherein said electrochemiluminescent label comprises an organometallic compound.

20. The composition of claim 18 , wherein said electrochemiluminescent label comprises a Ru-containing or Os-containing organometallic compound.

21. A kit suitable for use in forming an electrochemiluminescent composition for use in an electrochemiluminescent assay for an analyte of interest, comprising, in one or more containers:

(a) an electrochemiluminescent label;

(b) a first reagent comprising (i) a first binding partner of said analyte of interest or (ii) a first binding competitor of said analyte of interest;

(c) collectable magnetic particles;

(d) a second reagent comprising (i) a second binding partner of said analyte of interest or (ii) a second binding competitor of said analyte of interest; and

(e) an electrolyte.

22. The kit of claim 21 , wherein said electrochemiluminescent label comprises an organometallic compound.

23. The kit of claim 21 , wherein said electrochemiluminescent label comprises a Ru-containing or Os-containing organometallic compound.

24. A kit suitable for use in forming an electrochemiluminescent composition for use in an electrochemiluminescent assay for an analyte of interest, comprising, in one or more containers:

(a) an electrochemiluminescent label;

(b) a first binding reagent comprising a binding partner of (i) said analyte of interest, (ii) an analog of said analyte of interest, (iii) a binding partner of said analyte of interest, or (iv) a binding partner of said analog of said analyte of interest, wherein said first binding reagent is linked to or is also a binding partner of said label;

(c) collectable magnetic particles;

(d) a second binding reagent comprising a binding partner of (i) said analyte of interest, (ii) an analog of said analyte of interest, (iii) a binding partner of said analyte of interest, or (iv) a binding partner of said analog of said analyte of interest, wherein said second binding reagent is linked to or is also a binding partner of said particles; and

(e) an electrolyte

wherein said composition is suitable for use in said assay for said analyte of interest.

25. The kit of claim 24 , wherein said electrochemiluminescent label comprises an organometallic compound.

26. The kit of claim 24 , wherein said electrochemiluminescent label comprises a Ru-containing or Os-containing organometallic compound.

27. The composition of claim 1 , where said first binding reagent is linked to said electrochemiluminescent label.

28. The composition of claim 1 , wherein said second binding reagent is linked to said collectable magnetic particles.

29. The composition of claim 1 , wherein said first binding reagent is linked to said electrochemiluminescent label and said second binding reagent is linked to said collectable magnetic particles.

30. The composition of claim 1 , wherein said electrochemiluminescent label is linked to a reactive component and said reactive component is a binding partner of said first binding reagent.

31. The composition of claim 1 , wherein said collectable magnetic particles comprise a binding partner of said second binding reagent.

32. The composition of claim 1 , wherein said first binding reagent and said second binding reagent are both binding partners of said analyte.

33. The composition of claim 1 , wherein said first binding reagent is linked to said label and said second binding reagent is a binding partner of said particles.

34. The composition of claim 18 , where said first reagent is linked to said electrochemiluminescent label.

35. The composition of claim 18 , wherein said second reagent is linked to said collectable magnetic particles.

36. The composition of claim 18 , wherein said first reagent is liked to said electrochemiluminescent label and said second reagent is linked to said collectable magnetic particles.

37. The composition of claim 18 , wherein said electrochemiluminescent label is linked to a reactive component and said reactive component is a binding partner of said first reagent.

38. The composition of claim 18 , wherein said collectable magnetic particles comprise a binding partner of said second reagent.

39. The composition of claim 18 , wherein said first reagent and said second reagent are both binding partners of said analyte.

40. The composition of claim 18 , wherein said first reagent is linked to said label and said second reagent is a binding partner of said particles.

41. The kit of claim 21 , where said first reagent is linked to said electrochemiluminescent label.

42. The kit of claim 21 , wherein said second reagent is linked to said collectable magnetic particles.

43. The kit of claim 21 , wherein said first reagent is linked to said electrochemiluminescent label and said so reagent is linked to said collectable magnetic particle.

44. The kit of claim 21 , wherein said electrochemiluminescent label is linked to a reactive component and said reactive component is a binding partner of said first reagent.

45. The kit of claim 21 , wherein said collectable magnetic particles comprise a binding partner of said second reagent.

46. The kit of claim 21 , wherein said first reagent and said second reagent are both binding partners of said analyte.

47. The kit of claim 21 , wherein said first reagent is linked to said label and said second reagent is a binding partner of said particles.

48. The kit of claim 24 , where said first binding reagent is linked to said electrochemiluminescent label.

49. The kit of claim 24 , wherein said second binding reagent is linked to said collectable magnetic particles.

50. The kit of claim 24 , wherein said first binding reagent is linked to said electrochemiluminescent label and said second binding reagent is linked to said collectable magnetic particles.

51. The kit of claim 24 , wherein said electrochemiluminescent label is linked to a reactive component and said reactive component is a binding partner of said first binding reagent.

52. The kit of claim 24 , wherein said collectable magnetic particles comprise a binding partner of said second binding reagent.

53. The kit of claim 24 , wherein said first binding reagent and said second binding reagent are both binding partners of said analyte.

54. The kit of claim 24 , wherein said first binding reagent is linked to said label and said second binding reagent is a binding partner of said particles.

55. The composition of claim 1 , further comprising a reductant which can be oxidized to form a highly reducing species.

56. The composition of claim 1 , further comprising an amine or amine moiety.

57. The composition of claim 1 , further comprising an aliphatic amine.

58. The composition of claim 1 , further comprising tripropyl amine.

59. The composition of claim 1 , further comprising a substance which enhances electrochemiluminescence.

60. The composition of claim 18 , further comprising a reductant which can be oxidized to form a highly reducing species.

61. The composition of claim 18 , further comprising an amine or amine moiety.

62. The composition of claim 18 , further comprising an aliphatic amine.

63. The composition of claim 18 , further comprising tripropyl amine.

64. The composition of claim 18 , further comprising a substance which enhances electrochemiluminescence.

65. The kit of claim 21 , further comprising a reductant which can be oxidized to form a highly reducing species.

66. The kit of claim 21 , further comprising an amine or amine moiety.

67. The kit of claim 21 , further comprising an aliphatic amine.

68. The kit of claim 21 , further comprising tripropyl amine.

69. The kit of claim 21 , further comprising a substance which enhances electrochemiluminescence.

70. The kit of claim 24 , further comprising a reductant which can be oxidized to form a highly reducing species.

71. The kit of claim 24 , further comprising an amine or amine moiety.

72. The kit of claim 24 , further comprising an aliphatic amine.

73. The kit of claim 24 , further comprising tripropyl amine.

74. The kit of claim 24 , further comprising a substance which enhances electrochemiluminescence.

75. The composition of claim 18 , wherein:

said electrochemiluminescent label comprises an organometallic ruthenium complex;

said first reagent and said electrochemiluminescent label are covalently linked and said first reagent comprises said first binding partner of said analyte of interest;

said second reagent comprises said second binding partner of said analyte of interest and further comprises biotin and said second binding partner is covalently linked to said biotin; and

said collectable magnetic particles are coated with streptavidin and have a diameter of between 0.5 μm and 10 μm.

76. The composition of claim 75 , wherein said collectable magnetic particles comprise 2.8 μm diameter particles or 4.5 μm diameter particles.

77. The composition of claim 18 , wherein:

said electrochemiluminescent label comprises an organometallic ruthenium complex;

said first reagent and said electrochemiluminescent label are covalently linked and said first reagent comprises said first binding partner and said first binding partner is a first antibody specific for said analyte of interest;

said second binding reagent comprises said second binding partner and further comprises biotin, wherein said second binding reagent is a second antibody specific for said analyte of interest and is covalently linked to said biotin; and

said collectable magnetic particles are coated with streptavidin and have a diameter of between 0.5 μm and 10 μm.

78. The composition of claim 77 , wherein said collectable magnetic particles comprises 2.8 μm diameter particles or 4.5 μm diameter particles.

79. The kit of claim 21 , wherein:

said electrochemiluminescent label comprises an organometallic ruthenium complex;

said first reagent and said electrochemiluminescent label are covalently linked and said first reagent comprises said first binding partner of said analyte of interest;

said second reagent comprises said second binding partner of said analyte of interest and further comprises biotin and said second binding partner is covalently linked to said biotin; and

said collectable magnetic particles are coated with streptavidin and have a diameter of between 0.5 μm and 10 μm.

80. The kit of claim 79 , wherein said collectable magnetic particles comprise 2.8 μm diameter particles or 4.5 μm diameter particle.

81. The kit of claim 24 , wherein

said electrochemiluminescent label comprises an organometallic ruthenium complex;

said first reagent and said electrochemiluminescent label are covalently linked and said first reagent comprises said first binding partner and said first binding partner is a first antibody specific for said analyte of interest;

said second reagent comprises said second binding partner and further comprises biotin, wherein said second binding reagent is a second antibody specific for said analyte of interest and is covalently linked to said biotin; and

said collectable magnetic particles are coated with streptavidin and have a diameter of between 0.5 μm and 10 μm.

82. The kit of claim 81 , wherein said collectable magnetic particles comprise 2.8 μm diameter particles or 4.5 μm diameter particles.

83. The composition of claim 18 , wherein the first reagent and the second reagent differ in binding specificity.

84. The kit of claim 21 , wherein the first reagent and the second reagent differ in binding specificity.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015232/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015242/0799 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015248/0731 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2004
From: IGEN INTERNATIONAL, INC.
To: BIOVERIS CORPORATION
Reel/Frame 015249/0001 →
MERGER Recorded Aug 14, 1998
From: IGEN, INC.
To: IGEN INTERNATIONAL, INC.
Reel/Frame 009396/0070 →
Continuity (7)
Division 0834683200 · Nov 30, 1994
Continuation 0815819300 · Nov 24, 1993
Continuation 0765242700 · Feb 6, 1991
Continuation In Part 0753938900 · Jun 18, 1990
Continuation 0726688200 · Nov 3, 1988
Continuation In Part 0736956000
Continuation In Part 0685835400 · Apr 30, 1996